BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morris GP, Clark IA, Vissel B. Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease. Acta Neuropathol 2018;136:663-89. [PMID: 30349969 DOI: 10.1007/s00401-018-1918-8] [Cited by in Crossref: 103] [Cited by in F6Publishing: 84] [Article Influence: 25.8] [Reference Citation Analysis]
Number Citing Articles
1 Cheng F, Fransson LÅ, Mani K. Reversal of apolipoprotein E4-dependent or chemical-induced accumulation of APP degradation products by vitamin C-induced release of heparan sulfate from glypican-1. Glycobiology 2021:cwaa120. [PMID: 33403386 DOI: 10.1093/glycob/cwaa120] [Reference Citation Analysis]
2 Mullane K, Williams M. Preclinical Models of Alzheimer's Disease: Relevance and Translational Validity. Curr Protoc Pharmacol 2019;84:e57. [PMID: 30802363 DOI: 10.1002/cpph.57] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
3 Sun DY, Cheng C, Moschke K, Huang J, Fang WS. Extensive Structure Modification on Luteolin-Cinnamic Acid Conjugates Leading to BACE1 Inhibitors with Optimal Pharmacological Properties. Molecules 2019;25:E102. [PMID: 31888099 DOI: 10.3390/molecules25010102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Di Virgilio F, Jacobson KA, Williams M. Geoffrey Burnstock - An accidental pharmacologist. Biochem Pharmacol 2021;187:114300. [PMID: 33203518 DOI: 10.1016/j.bcp.2020.114300] [Reference Citation Analysis]
5 Meikle SR, Sossi V, Roncali E, Cherry SR, Banati R, Mankoff D, Jones T, James M, Sutcliffe J, Ouyang J, Petibon Y, Ma C, El Fakhri G, Surti S, Karp JS, Badawi RD, Yamaya T, Akamatsu G, Schramm G, Rezaei A, Nuyts J, Fulton R, Kyme A, Lois C, Sari H, Price J, Boellaard R, Jeraj R, Bailey DL, Eslick E, Willowson KP, Dutta J. Quantitative PET in the 2020s: a roadmap. Phys Med Biol 2021;66:06RM01. [PMID: 33339012 DOI: 10.1088/1361-6560/abd4f7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Pulina MV, Hopkins M, Haroutunian V, Greengard P, Bustos V. C99 selectively accumulates in vulnerable neurons in Alzheimer's disease. Alzheimer's & Dementia 2020;16:273-82. [DOI: 10.1016/j.jalz.2019.09.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
7 Hampel H, Lista S, Neri C, Vergallo A. Time for the systems-level integration of aging: Resilience enhancing strategies to prevent Alzheimer’s disease. Progress in Neurobiology 2019;181:101662. [DOI: 10.1016/j.pneurobio.2019.101662] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
8 Barthelson K, Newman M, Nowell CJ, Lardelli M. No observed effect on brain vasculature of Alzheimer's disease-related mutations in the zebrafish presenilin 1 gene. Mol Brain 2021;14:22. [PMID: 33494778 DOI: 10.1186/s13041-021-00734-5] [Reference Citation Analysis]
9 Cenini G, Voos W. Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update. Front Pharmacol 2019;10:902. [PMID: 31507410 DOI: 10.3389/fphar.2019.00902] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 21.0] [Reference Citation Analysis]
10 Handy A, Lord J, Green R, Xu J, Aarsland D, Velayudhan L, Hye A, Dobson R, Proitsi P; Alzheimer’s Disease Neuroimaging initiative., AddNeuroMed, and the GERAD1 Consortium. Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer's Disease. J Alzheimers Dis 2021;83:1825-39. [PMID: 34459398 DOI: 10.3233/JAD-210462] [Reference Citation Analysis]
11 Delport A, Hewer R. The amyloid precursor protein: a converging point in Alzheimer's disease. Mol Neurobiol 2022. [PMID: 35579846 DOI: 10.1007/s12035-022-02863-x] [Reference Citation Analysis]
12 Srivastava S, Ahmad R, Khare SK. Alzheimer's disease and its treatment by different approaches: A review. Eur J Med Chem 2021;216:113320. [PMID: 33652356 DOI: 10.1016/j.ejmech.2021.113320] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
13 Li H, Liu CC, Zheng H, Huang TY. Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer's disease -conformist, nonconformist, and realistic prospects for AD pathogenesis. Transl Neurodegener 2018;7:34. [PMID: 30603085 DOI: 10.1186/s40035-018-0139-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
14 Mandino F, Yeow LY, Bi R, Sejin L, Bae HG, Baek SH, Lee CY, Mohammad H, Horien C, Teoh CL, Lee JH, Lai MK, Jung S, Fu Y, Olivo M, Gigg J, Grandjean J. The lateral entorhinal cortex is a hub for local and global dysfunction in early Alzheimer's disease states. J Cereb Blood Flow Metab 2022;:271678X221082016. [PMID: 35466772 DOI: 10.1177/0271678X221082016] [Reference Citation Analysis]
15 Xu QQ, Shaw PC, Hu Z, Yang W, Ip SP, Xian YF, Lin ZX. Comparison of the chemical constituents and anti-Alzheimer's disease effects of Uncaria rhynchophylla and Uncaria tomentosa. Chin Med 2021;16:110. [PMID: 34706756 DOI: 10.1186/s13020-021-00514-2] [Reference Citation Analysis]
16 Liao W, Zheng Y, Fang W, Liao S, Xiong Y, Li Y, Xiao S, Zhang X, Liu J. Dual Specificity Phosphatase 6 Protects Neural Stem Cells from β-Amyloid-Induced Cytotoxicity through ERK1/2 Inactivation. Biomolecules 2018;8:E181. [PMID: 30572643 DOI: 10.3390/biom8040181] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
17 Jellinger KA. Neuropathological assessment of the Alzheimer spectrum. J Neural Transm (Vienna) 2020;127:1229-56. [PMID: 32740684 DOI: 10.1007/s00702-020-02232-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
18 Panza F, Lozupone M, Watling M, Imbimbo BP. Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease? Expert Rev Neurother 2019;19:599-602. [PMID: 31112433 DOI: 10.1080/14737175.2019.1621751] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
19 Ayton S, Bush AI. β-amyloid: The known unknowns. Ageing Res Rev 2021;65:101212. [PMID: 33188924 DOI: 10.1016/j.arr.2020.101212] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 18.0] [Reference Citation Analysis]
20 Cavedo E, Lista S, Houot M, Vergallo A, Grothe MJ, Teipel S, Zetterberg H, Blennow K, Habert M, Potier MC, Dubois B, Hampel H; for the INSIGHT-preAD Study Group and the Alzheimer Precision Medicine Initiative. Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease. Neurology 2019;94:e30-41. [DOI: 10.1212/wnl.0000000000008696] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
21 Lövdén M, Fratiglioni L, Glymour MM, Lindenberger U, Tucker-Drob EM. Education and Cognitive Functioning Across the Life Span. Psychol Sci Public Interest 2020;21:6-41. [PMID: 32772803 DOI: 10.1177/1529100620920576] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 39.0] [Reference Citation Analysis]
22 Xu L, Tian S, Peng X, Hua Y, Yang W, Chen L, Liu S, Wu W, Zhao J, He J, Wu L, Yang J, Zheng Y. Clusterin inhibits Aβ42 aggregation through a "strawberry model" as detected by FRET-FCS. J Neurochem 2021;158:444-54. [PMID: 33694231 DOI: 10.1111/jnc.15344] [Reference Citation Analysis]
23 Rivas-fernández MÁ, Lindín M, Zurrón M, Díaz F, Aldrey-vázquez JM, Pías-peleteiro JM, Vázquez-vázquez L, Pereiro AX, Lojo-seoane C, Nieto-vieites A, Galdo-álvarez S. Brain Atrophy and Clinical Characterization of Adults With Mild Cognitive Impairment and Different Cerebrospinal Fluid Biomarker Profiles According to the AT(N) Research Framework of Alzheimer’s Disease. Front Hum Neurosci 2022;16:799347. [DOI: 10.3389/fnhum.2022.799347] [Reference Citation Analysis]
24 Xu Y, Zhao M, Han Y, Zhang H. GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment. Front Neurosci 2020;14:660. [PMID: 32714136 DOI: 10.3389/fnins.2020.00660] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
25 Atlante A, Amadoro G, Bobba A, Latina V. Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer's Disease. Cells 2020;9:E2347. [PMID: 33114170 DOI: 10.3390/cells9112347] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
26 Daskalaki I, Tavernarakis N. Mitochondrial biogenesis in organismal senescence and neurodegeneration. Mechanisms of Ageing and Development 2020;191:111345. [DOI: 10.1016/j.mad.2020.111345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Clark IA, Vissel B. Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective – a Commentary. Expert Review of Neurotherapeutics 2019;19:535-43. [DOI: 10.1080/14737175.2019.1618710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
28 Yiannopoulou KG, Anastasiou AI, Zachariou V, Pelidou SH. Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research. Biomedicines 2019;7:E97. [PMID: 31835422 DOI: 10.3390/biomedicines7040097] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 24.7] [Reference Citation Analysis]
29 Engin AB, Engin A. Alzheimer's Disease and Protein Kinases. Adv Exp Med Biol 2021;1275:285-321. [PMID: 33539020 DOI: 10.1007/978-3-030-49844-3_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
30 [DOI: 10.1101/487629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 van Oostveen WM, de Lange ECM. Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring. Int J Mol Sci 2021;22:2110. [PMID: 33672696 DOI: 10.3390/ijms22042110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 McKenzie BA, Dixit VM, Power C. Fiery Cell Death: Pyroptosis in the Central Nervous System. Trends Neurosci 2020;43:55-73. [PMID: 31843293 DOI: 10.1016/j.tins.2019.11.005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 12.0] [Reference Citation Analysis]
33 Clark IA. Background to new treatments for COVID-19, including its chronicity, through altering elements of the cytokine storm. Rev Med Virol 2021;31:1-13. [PMID: 33580566 DOI: 10.1002/rmv.2210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Bovijn J, Censin JC, Lindgren CM, Holmes MV. Commentary: Using human genetics to guide the repurposing of medicines. Int J Epidemiol 2020;49:1140-6. [PMID: 32097451 DOI: 10.1093/ije/dyaa015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
35 Kan Z, Wang Y, Chen Q, Tang X, Thompson HJ, Huang J, Zhang J, Gao F, Shen Y, Wan X. Green Tea Suppresses Amyloid β Levels and Alleviates Cognitive Impairment by Inhibiting APP Cleavage and Preventing Neurotoxicity in 5XFAD Mice. Mol Nutr Food Res 2021;:e2100626. [PMID: 34342385 DOI: 10.1002/mnfr.202100626] [Reference Citation Analysis]
36 Idland AV, Sala-Llonch R, Watne LO, Brækhus A, Hansson O, Blennow K, Zetterberg H, Sørensen Ø, Walhovd KB, Wyller TB, Fjell AM. Biomarker profiling beyond amyloid and tau: cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults. Neurobiol Aging 2020;93:1-15. [PMID: 32438258 DOI: 10.1016/j.neurobiolaging.2020.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Too LK, Hunt N, Simunovic MP. The Role of Inflammation and Infection in Age-Related Neurodegenerative Diseases: Lessons From Bacterial Meningitis Applied to Alzheimer Disease and Age-Related Macular Degeneration. Front Cell Neurosci 2021;15:635486. [PMID: 33867940 DOI: 10.3389/fncel.2021.635486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Krafft GA, Jerecic J, Siemers E, Cline EN. ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease. Front Neurosci 2022;16:848215. [DOI: 10.3389/fnins.2022.848215] [Reference Citation Analysis]
39 Johnson RJ, Gomez-Pinilla F, Nagel M, Nakagawa T, Rodriguez-Iturbe B, Sanchez-Lozada LG, Tolan DR, Lanaspa MA. Cerebral Fructose Metabolism as a Potential Mechanism Driving Alzheimer's Disease. Front Aging Neurosci 2020;12:560865. [PMID: 33024433 DOI: 10.3389/fnagi.2020.560865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
40 Ashford JW. The Dichotomy of Alzheimer's Disease Pathology: Amyloid-β and Tau. J Alzheimers Dis 2019;68:77-83. [PMID: 30814359 DOI: 10.3233/JAD-181198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
41 Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A. The Amyloid-β Pathway in Alzheimer's Disease. Mol Psychiatry 2021. [PMID: 34456336 DOI: 10.1038/s41380-021-01249-0] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 49.0] [Reference Citation Analysis]
42 Bomba M, Granzotto A, Castelli V, Onofrj M, Lattanzio R, Cimini A, Sensi SL. Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease. J Alzheimers Dis 2019;70:793-810. [PMID: 31256135 DOI: 10.3233/JAD-190237] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
43 Liu J, Chang L, Song Y, Li H, Wu Y. The Role of NMDA Receptors in Alzheimer's Disease. Front Neurosci 2019;13:43. [PMID: 30800052 DOI: 10.3389/fnins.2019.00043] [Cited by in Crossref: 77] [Cited by in F6Publishing: 75] [Article Influence: 25.7] [Reference Citation Analysis]
44 Kang J, Nam JS, Lee HJ, Nam G, Rhee HW, Kwon TH, Lim MH. Chemical strategies to modify amyloidogenic peptides using iridium(iii) complexes: coordination and photo-induced oxidation. Chem Sci 2019;10:6855-62. [PMID: 31391908 DOI: 10.1039/c9sc00931k] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
45 Young KZ, Lee SJ, Zhang X, Cartee NMP, Torres M, Keep SG, Gabbireddy SR, Fontana JL, Qi L, Wang MM. NOTCH3 is non-enzymatically fragmented in inherited cerebral small-vessel disease. J Biol Chem 2020;295:1960-72. [PMID: 31901894 DOI: 10.1074/jbc.RA119.007724] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
46 Aaseth J, Buha A, Wallace DR, Bjørklund G. Xenobiotics, Trace Metals and Genetics in the Pathogenesis of Tauopathies. Int J Environ Res Public Health 2020;17:E1269. [PMID: 32079163 DOI: 10.3390/ijerph17041269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 Hegde AN, Smith SG, Duke LM, Pourquoi A, Vaz S. Perturbations of Ubiquitin-Proteasome-Mediated Proteolysis in Aging and Alzheimer's Disease. Front Aging Neurosci 2019;11:324. [PMID: 31866849 DOI: 10.3389/fnagi.2019.00324] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
48 Chang CH, Lin CH, Lane HY. Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease. Int J Mol Sci 2021;22:2761. [PMID: 33803217 DOI: 10.3390/ijms22052761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Kaeser GE, Chun J. Mosaic Somatic Gene Recombination as a Potentially Unifying Hypothesis for Alzheimer's Disease. Front Genet 2020;11:390. [PMID: 32457796 DOI: 10.3389/fgene.2020.00390] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
50 Massetti N, Russo M, Franciotti R, Nardini D, Mandolini G, Granzotto A, Bomba M, Delli Pizzi S, Mosca A, Scherer R, Onofrj M, Sensi SL; Alzheimer’s Disease Neuroimaging Initiative (ADNI)., Alzheimer’s Disease Metabolomics Consortium (ADMC). A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum. J Alzheimers Dis 2021. [PMID: 34958014 DOI: 10.3233/JAD-210573] [Reference Citation Analysis]
51 Talwar P, Kushwaha S, Gupta R, Agarwal R. Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer's Disease. Front Aging Neurosci 2019;11:290. [PMID: 31736740 DOI: 10.3389/fnagi.2019.00290] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
52 Eysert F, Coulon A, Boscher E, Vreulx A, Flaig A, Mendes T, Hughes S, Grenier-boley B, Hanoulle X, Demiautte F, Bauer C, Marttinen M, Takalo M, Amouyel P, Desai S, Pike I, Hiltunen M, Chécler F, Farinelli M, Delay C, Malmanche N, Hébert SS, Dumont J, Kilinc D, Lambert J, Chapuis J. Alzheimer’s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner. Mol Psychiatry. [DOI: 10.1038/s41380-020-00926-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
53 Esselun C, Bruns B, Hagl S, Grewal R, Eckert GP. Impact of Silibinin A on Bioenergetics in PC12APPsw Cells and Mitochondrial Membrane Properties in Murine Brain Mitochondria. Antioxidants (Basel) 2021;10:1520. [PMID: 34679655 DOI: 10.3390/antiox10101520] [Reference Citation Analysis]
54 Hicks AJ, James AC, Spitz G, Ponsford JL. Traumatic Brain Injury as a Risk Factor for Dementia and Alzheimer Disease: Critical Review of Study Methodologies. J Neurotrauma 2019;36:3191-219. [PMID: 31111768 DOI: 10.1089/neu.2018.6346] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
55 Ebrahimi K, Jourkesh M, Sadigh-Eteghad S, Stannard SR, Earnest CP, Ramsbottom R, Antonio J, Navin KH. Effects of Physical Activity on Brain Energy Biomarkers in Alzheimer's Diseases. Diseases 2020;8:E18. [PMID: 32521816 DOI: 10.3390/diseases8020018] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Mullane K, Williams M. The de-Alzheimerization of age-related dementias: implications for drug targets and approaches to effective therapeutics. Curr Opin Pharmacol 2019;44:62-75. [PMID: 30795894 DOI: 10.1016/j.coph.2019.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
57 Kim HR, Lee T, Choi JK, Jeong Y; Alzheimer's Disease Neuroimaging Initiative. Genetic variants beyond amyloid and tau associated with cognitive decline: A cohort study. Neurology 2020;95:e2366-77. [PMID: 32938779 DOI: 10.1212/WNL.0000000000010724] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Pluta R, Januszewski S, Czuczwar SJ. Brain Ischemia as a Prelude to Alzheimer's Disease. Front Aging Neurosci 2021;13:636653. [PMID: 33679381 DOI: 10.3389/fnagi.2021.636653] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
59 Pistollato F, Bernasconi C, McCarthy J, Campia I, Desaintes C, Wittwehr C, Deceuninck P, Whelan M. Alzheimer's Disease, and Breast and Prostate Cancer Research: Translational Failures and the Importance to Monitor Outputs and Impact of Funded Research. Animals (Basel) 2020;10:E1194. [PMID: 32674379 DOI: 10.3390/ani10071194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
60 Liss JL, Seleri Assunção S, Cummings J, Atri A, Geldmacher DS, Candela SF, Devanand DP, Fillit HM, Susman J, Mintzer J, Bittner T, Brunton SA, Kerwin DR, Jackson WC, Small GW, Grossberg GT, Clevenger CK, Cotter V, Stefanacci R, Wise-Brown A, Sabbagh MN. Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis. J Intern Med 2021;290:310-34. [PMID: 33458891 DOI: 10.1111/joim.13244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
61 Eadie AL, Brunt KR, Herder M. Exploring the Food and Drug Administration's review and approval of Entresto (sacubitril/valsartan). Pharmacol Res Perspect 2021;9:e00794. [PMID: 34087050 DOI: 10.1002/prp2.794] [Reference Citation Analysis]
62 Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, Hokkanen SRK, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murayama S, Murray ME, Nag S, Rissman RA, Seeley WW, Sperling RA, White Iii CL, Yu L, Schneider JA. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 2019;142:1503-27. [PMID: 31039256 DOI: 10.1093/brain/awz099] [Cited by in Crossref: 348] [Cited by in F6Publishing: 319] [Article Influence: 174.0] [Reference Citation Analysis]
63 Mcrae-mckee K, Udeh-momoh CT, Price G, Bajaj S, de Jager CA, Scott D, Hadjichrysanthou C, Mcnaughton E, Bracoud L, Ahmadi-abhari S, de Wolf F, Anderson RM, Middleton LT; Alzheimer's Disease Neuroimaging Initiative. Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a “gray zone”? Alzheimer's & Dementia 2019;15:1348-56. [DOI: 10.1016/j.jalz.2019.07.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
64 Hashweh NN, Bartochowski Z, Khoury R, Grossberg GT. An evaluation of hydromethylthionine as a treatment option for Alzheimer's disease. Expert Opin Pharmacother 2020;21:619-27. [PMID: 32037892 DOI: 10.1080/14656566.2020.1719066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
65 Kwan P, Konno H, Chan KY, Baum L. Rationale for the development of an Alzheimer's disease vaccine. Hum Vaccin Immunother 2020;16:645-53. [PMID: 31526227 DOI: 10.1080/21645515.2019.1665453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
66 Mao Y. Structure, Dynamics and Function of the 26S Proteasome. Subcell Biochem 2021;96:1-151. [PMID: 33252727 DOI: 10.1007/978-3-030-58971-4_1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
67 Ahmad SS, Kamal MA. Current Updates on the Regulation of Beta-Secretase Movement as a Potential Restorative Focus for Management of Alzheimer's Disease. PPL 2019;26:579-87. [DOI: 10.2174/0929866526666190405125334] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, Herholz K, Hutton BF, Jack CR Jr, Lammertsma AA, Landau SM, Minoshima S, Nobili F, Nordberg A, Ossenkoppele R, Oyen WJG, Perani D, Rabinovici GD, Scheltens P, Villemagne VL, Zetterberg H, Drzezga A. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. Lancet Neurol 2020;19:951-62. [PMID: 33098804 DOI: 10.1016/S1474-4422(20)30314-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 22] [Article Influence: 22.5] [Reference Citation Analysis]
69 Zhang J, Wu N, Wang S, Yao Z, Xiao F, Lu J, Chen B. Neuronal loss and microgliosis are restricted to the core of Aβ deposits in mouse models of Alzheimer's disease. Aging Cell 2021;20:e13380. [PMID: 34080759 DOI: 10.1111/acel.13380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
70 Xiong X, Li S, Han TL, Zhou F, Zhang X, Tian M, Tang L, Li Y. Study of mitophagy and ATP-related metabolomics based on β-amyloid levels in Alzheimer's disease. Exp Cell Res 2020;396:112266. [PMID: 32905804 DOI: 10.1016/j.yexcr.2020.112266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
71 Arnsten AFT, Datta D, Tredici KD, Braak H. Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease. Alzheimers Dement 2021;17:115-24. [PMID: 33075193 DOI: 10.1002/alz.12192] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
72 Zhuo J, Zhang Y, Liu Y, Liu B, Zhou X, Bartlett PF, Jiang T; Alzheimer’s Disease Neuroimaging Initiative. New Trajectory of Clinical and Biomarker Changes in Sporadic Alzheimer's Disease. Cereb Cortex 2021;31:3363-73. [PMID: 33690839 DOI: 10.1093/cercor/bhab017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Roda AR, Montoliu-Gaya L, Villegas S. The Role of Apolipoprotein E Isoforms in Alzheimer's Disease. J Alzheimers Dis 2019;68:459-71. [PMID: 30775980 DOI: 10.3233/JAD-180740] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
74 Riccardi C, Napolitano F, Montesarchio D, Sampaolo S, Melone MAB. Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases. Pharmaceutics 2021;13:1897. [PMID: 34834311 DOI: 10.3390/pharmaceutics13111897] [Reference Citation Analysis]
75 Jankovska N, Olejar T, Matej R. Extracellular Amyloid Deposits in Alzheimer's and Creutzfeldt-Jakob Disease: Similar Behavior of Different Proteins? Int J Mol Sci 2020;22:E7. [PMID: 33374972 DOI: 10.3390/ijms22010007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
76 Zhang B, Zhao J, Wang Z, Guo P, Liu A, Du G. Identification of Multi-Target Anti-AD Chemical Constituents From Traditional Chinese Medicine Formulae by Integrating Virtual Screening and In Vitro Validation. Front Pharmacol 2021;12:709607. [PMID: 34335272 DOI: 10.3389/fphar.2021.709607] [Reference Citation Analysis]
77 Mullane K, Williams M. Alzheimer’s disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery? Biochemical Pharmacology 2020;177:113945. [DOI: 10.1016/j.bcp.2020.113945] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
78 Wei Z, Koya J, Reznik SE. Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms. Front Neurosci 2021;15:687157. [PMID: 34349617 DOI: 10.3389/fnins.2021.687157] [Reference Citation Analysis]
79 Kola A, Hecel A, Lamponi S, Valensin D. Novel Perspective on Alzheimer's Disease Treatment: Rosmarinic Acid Molecular Interplay with Copper(II) and Amyloid β. Life (Basel) 2020;10:E118. [PMID: 32698429 DOI: 10.3390/life10070118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Young JK. Neurogenesis Makes a Crucial Contribution to the Neuropathology of Alzheimer's Disease. J Alzheimers Dis Rep 2020;4:365-71. [PMID: 33163897 DOI: 10.3233/ADR-200218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Pluta R. Brain ischemia as a bridge to Alzheimer's disease. Neural Regen Res 2022;17:791-2. [PMID: 34472473 DOI: 10.4103/1673-5374.322453] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
82 Furcila D, Domínguez-Álvaro M, DeFelipe J, Alonso-Nanclares L. Subregional Density of Neurons, Neurofibrillary Tangles and Amyloid Plaques in the Hippocampus of Patients With Alzheimer's Disease. Front Neuroanat 2019;13:99. [PMID: 31920568 DOI: 10.3389/fnana.2019.00099] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
83 Hin N, Newman M, Kaslin J, Douek AM, Lumsden A, Nik SHM, Dong Y, Zhou XF, Mañucat-Tan NB, Ludington A, Adelson DL, Pederson S, Lardelli M. Accelerated brain aging towards transcriptional inversion in a zebrafish model of the K115fs mutation of human PSEN2. PLoS One 2020;15:e0227258. [PMID: 31978074 DOI: 10.1371/journal.pone.0227258] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
84 Kasper S, Bancher C, Eckert A, Förstl H, Frölich L, Hort J, Korczyn AD, Kressig RW, Levin O, Palomo MSM. Management of mild cognitive impairment (MCI): The need for national and international guidelines. World J Biol Psychiatry 2020;21:579-94. [PMID: 32019392 DOI: 10.1080/15622975.2019.1696473] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 18.5] [Reference Citation Analysis]
85 Weigand AJ, Bangen KJ, Thomas KR, Delano-Wood L, Gilbert PE, Brickman AM, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative. Is tau in the absence of amyloid on the Alzheimer's continuum?: A study of discordant PET positivity. Brain Commun 2020;2:fcz046. [PMID: 32051933 DOI: 10.1093/braincomms/fcz046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
86 Panza F, Lozupone M, Bellomo A, Imbimbo BP. Do anti-amyloid-β drugs affect neuropsychiatric status in Alzheimer's disease patients? Ageing Res Rev 2019;55:100948. [PMID: 31454563 DOI: 10.1016/j.arr.2019.100948] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]